OBJECTIVES: High-risk human papillomavirus (HR-HPV) infection is the most common sexually transmitted infection. Penile and cervical cancer rates are highest in sub-Saharan Africa. However, little is known about the impact of HIV infection on HR-HPV acquisition and clearance among heterosexual men. DESIGN: HR-HPV incidence and clearance were evaluated in 999 men (776 HIV-negative and 223 HIV-positive) aged 15-49 years who participated in male circumcision trials in Rakai, Uganda. METHODS: Penile swabs were tested for HR-HPV by Roche HPV Linear Array. A Poisson multivariable model was used to estimate adjusted incidence rate ratios (adjIRRs) and clearance risk ratios (adjRRs). RESULTS: HR-HPV incidence was 66.5/100 person-years in HIV-positive men and 32.9/100 person-years among HIV-negative men [IRR=2.02, 95% confidence interval (CI) 1.67-2.44]. Incidence was higher in the unmarried men (adjIRR=1.73, 95% CI 1.19-2.52), and decreased with age (adjIRR for men >35 years=0.64, 95% CI 0.43-0.94) and male circumcision (adjIRR=0.70, 95% CI 0.55-0.89). HR-HPV clearance was 114.7/100 person-years for HIV-positive men and 170.2/100 person-years for HIV-negative men (risk ratio=0.67, 95% CI 0.59-0.77). HR-HPV clearance in HIV-negative men increased with circumcision (adjRR=1.48, 95% CI 1.26-1.74), HSV-2 infection (adjRR=1.20, 95% CI 1.01-1.44), and symptoms of urethral discharge (adjRR=1.35, 95% CI 1.06-1.73). Clearance of HR-HPV was significantly lower for unmarried men (adjRR 0.76, 95% CI 0.59-0.98). CONCLUSION: HR-HPV is common among heterosexual Ugandan men, particularly the HIV-infected. HIV infection increases HR-HPV acquisition and reduces HR-HPV clearance. Promotion of male circumcision and additional prevention measures, such as HPV vaccination, is critical in sub-Saharan Africa.
OBJECTIVES: High-risk human papillomavirus (HR-HPV) infection is the most common sexually transmitted infection. Penile and cervical cancer rates are highest in sub-Saharan Africa. However, little is known about the impact of HIV infection on HR-HPV acquisition and clearance among heterosexual men. DESIGN:HR-HPV incidence and clearance were evaluated in 999 men (776 HIV-negative and 223 HIV-positive) aged 15-49 years who participated in male circumcision trials in Rakai, Uganda. METHODS: Penile swabs were tested for HR-HPV by Roche HPV Linear Array. A Poisson multivariable model was used to estimate adjusted incidence rate ratios (adjIRRs) and clearance risk ratios (adjRRs). RESULTS:HR-HPV incidence was 66.5/100 person-years in HIV-positive men and 32.9/100 person-years among HIV-negative men [IRR=2.02, 95% confidence interval (CI) 1.67-2.44]. Incidence was higher in the unmarried men (adjIRR=1.73, 95% CI 1.19-2.52), and decreased with age (adjIRR for men >35 years=0.64, 95% CI 0.43-0.94) and male circumcision (adjIRR=0.70, 95% CI 0.55-0.89). HR-HPV clearance was 114.7/100 person-years for HIV-positive men and 170.2/100 person-years for HIV-negative men (risk ratio=0.67, 95% CI 0.59-0.77). HR-HPV clearance in HIV-negative men increased with circumcision (adjRR=1.48, 95% CI 1.26-1.74), HSV-2 infection (adjRR=1.20, 95% CI 1.01-1.44), and symptoms of urethral discharge (adjRR=1.35, 95% CI 1.06-1.73). Clearance of HR-HPV was significantly lower for unmarried men (adjRR 0.76, 95% CI 0.59-0.98). CONCLUSION:HR-HPV is common among heterosexual Ugandan men, particularly the HIV-infected. HIV infection increases HR-HPV acquisition and reduces HR-HPV clearance. Promotion of male circumcision and additional prevention measures, such as HPV vaccination, is critical in sub-Saharan Africa.
Authors: Danielle M Backes; Maaike C G Bleeker; Chris J L M Meijer; Michael G Hudgens; Kawango Agot; Robert C Bailey; J O Ndinya-Achola; Juma Hayombe; Cornelis J A Hogewoning; Stephen Moses; Peter J F Snijders; Jennifer S Smith Journal: Int J Cancer Date: 2011-08-02 Impact factor: 7.396
Authors: Xavier Castellsagué; F Xavier Bosch; Nubia Muñoz; Chris J L M Meijer; Keerti V Shah; Silvia de Sanjose; José Eluf-Neto; Corazon A Ngelangel; Saibua Chichareon; Jennifer S Smith; Rolando Herrero; Victor Moreno; Silvia Franceschi Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: E I Svare; S K Kjaer; A M Worm; A Osterlind; C J L M Meijer; A J C van den Brule Journal: Sex Transm Infect Date: 2002-06 Impact factor: 3.519
Authors: N Coleman; H D Birley; A M Renton; N F Hanna; B K Ryait; M Byrne; D Taylor-Robinson; M A Stanley Journal: Am J Clin Pathol Date: 1994-12 Impact factor: 2.493
Authors: Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer Journal: N Engl J Med Date: 2003-02-06 Impact factor: 91.245
Authors: M Hippeläinen; S Syrjänen; M Hippeläinen; H Koskela; J Pulkkinen; S Saarikoski; K Syrjänen Journal: Sex Transm Dis Date: 1993 Nov-Dec Impact factor: 2.830
Authors: Aaron A R Tobian; Mary K Grabowski; Godfrey Kigozi; Patti E Gravitt; Kevin P Eaton; David Serwadda; Fred Nalugoda; Maria J Wawer; Thomas C Quinn; Ronald H Gray Journal: Sex Transm Infect Date: 2012-05-24 Impact factor: 3.519
Authors: Mary K Grabowski; Patti E Gravitt; Ronald H Gray; David Serwadda; Andrew D Redd; Godfrey Kigozi; Xiangrong Kong; Fred Nalugoda; Maria J Wawer; Thomas C Quinn; Aaron A R Tobian Journal: J Infect Dis Date: 2017-03-01 Impact factor: 5.226
Authors: Mary K Grabowski; Ronald H Gray; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Steven J Reynolds; Maria J Wawer; Stephen Watya; Thomas C Quinn; Aaron A R Tobian Journal: Sex Transm Infect Date: 2014-01-30 Impact factor: 3.519
Authors: Aaron A R Tobian; Mary K Grabowski; Godfrey Kigozi; Andrew D Redd; Kevin P Eaton; David Serwadda; Toby C Cornish; Fred Nalugoda; Stephen Watya; Denis Buwembo; James Nkale; Maria J Wawer; Thomas C Quinn; Ronald H Gray Journal: J Infect Dis Date: 2013-01-23 Impact factor: 5.226
Authors: Mitzie-Ann Davis; Ronald H Gray; Mary K Grabowski; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Stephen Watya; Maria J Wawer; Thomas C Quinn; Aaron A R Tobian Journal: Int J Cancer Date: 2013-03-07 Impact factor: 7.396
Authors: Danielle M Backes; Peter J F Snijders; Michael G Hudgens; Robert C Bailey; Martijn Bogaarts; Kawango Agot; Walter Agingu; Stephen Moses; Chris J L M Meijer; Jennifer S Smith Journal: Sex Transm Infect Date: 2012-09-01 Impact factor: 3.519
Authors: Sara E Oliver; Pamina M Gorbach; Beau Gratzer; Martin Steinau; Tom Collins; Adam Parrish; Peter R Kerndt; Richard A Crosby; Elizabeth R Unger; Lauri E Markowitz; Elissa Meites Journal: Sex Transm Dis Date: 2018-10 Impact factor: 2.830